GSK pulls Tykerb-plus-Herceptin app; CA county wants to bill pharma for pill disposal;

 @FiercePharma: Failing with Forest CEO, Icahn is now pressing non-exec board members to settle proxy contest--Reuters. More | Follow @FiercePharma

> GlaxoSmithKline ($GSK) pulled its application to market its breast cancer drug Tykerb for use in combination with Roche's ($RHHBY) Herceptin, saying FDA's questions about the new use couldn't be addressed with current data. Report

> A California county wants to require drugmakers to foot the bill for proper disposal of prescription drugs. Report

> Pfizer ($PFE) recalled Robitussin cough syrup in the Philippines because of dosing errors on product packaging. Report

> The Federal Trade Commission asked Watson Pharmaceuticals ($WPI) for more information about its proposed $5.6 billion buyout of genericsmaker Actavis. Report

> Bayer agreed to pay $15 million to settle a lawsuit claiming it illegally marketed aspirin combined with dietary supplments. Report

Biotech News

 @FierceBiotech: Duke and Scripps grab $31M for HIV /AIDS vaccine research, $186M to be awarded over six years. Story | Follow @FierceBiotech

 @JohnCFierce: Ascletis gets China development rights to Alnylam liver cancer drug - no terms announced. More | Follow @JohnCFierce

 @RyanMFierce: Here's $PFE 's 2011 ASCO poster on the FAK inhibitor. Item | Follow @RyanMFierce

> In deal flurry, Verastem vaults to PhII on Pfizer cancer drug pact. Story

> Merck's osteoporosis drug 'odana' clinches promising PhIII data. Item

> Actelion will slash 135 staffers, refocus on rare diseases in R&D shakeup. More

> New Kala CEO plans to raise funds for particle tech programs. Report

> GSK preps FDA app after albiglutide beats Januvia in Harmony 8. Article

Medical Device News

@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

@MarkHFierce: Hologic's acquisition of Gen-Probe closes at the end of the month. More | Follow @MarkHFierce

@DamianFierce: Becton Dickinson has bought Safety Syringes to boost its injectables business. Item | Follow @DamianFierce

> J&J confronts lawsuits over another all-metal hip implant. Story

> FDA slaps Class I tag on GE's ventilator recall. Article

> Covidien responds to FDA safety alert for Onyx liquid embolic product. Item

CRO News

 @NesaNFierce: ERT is striking the ePRO iron while it's hot, purchasing Invivodata. How many CROs take advantage of electronic data? Story | Follow @NesaNFierce

> Study shows no difference in data quality from CROs in developing countries. News

> Pharma cuts mean more expertise for CROs. Article

> Toshiba's latest TV ad doesn't leave ACRO laughing. Story

> EU preps simplified clinical trial rules for drug developers. News

> Polish market for clinical trials grows. Item

Pharma Manufacturing News

 @EricPFierce: Flooding leads to mold, leads to recall, leads to cancer drug shortage for Sanofi. More | Follow @EricPFierce

> Ephedrine scandal entangles legit drugmaking. Report

> Bristol-Myers expanding again in Puerto Rico. Story

> Kaluga Russia sets itself up as drugmaking epicenter. News

> Hospira shortage can't be blamed for woman's blindness. Article

> Mold leads to Sanofi cancer drug shortage. More

Vaccines News

> Norway's Bionor snags $1.7 million for HIV vaccine research. Article

> Australia backs plan to give HPV vax Gardasil to boys. More

> Duke and Scripps grab $31M for HIV/AIDS vax research. News

And Finally... Want to avoid the sitting-at-a-desk death sentence? Put motion sensors on your office lights. Report